NEW YORK, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in cellular medicines for inflammatory diseases, will provide a corporate update during an analyst call today. The webcast will begin at 8.30pm EDT Monday September 9, 2019; 10.30am AEST Tuesday September 10, 2019.
The webcast can be accessed via https://webcasting.boardroom.media/broadcast/5d71f3b98ab2617d254fa91c
To access the call only, dial 1 855 881 1339 (U.S.), 1 800 558 698 (toll-free Australia) or +61 2 9007 3187 (outside of the U.S. and Australia). The conference identification code is 10002044.
| For further information, please contact: | |
| Julie Meldrum | Schond Greenway |
| Corporate Communications | Investor Relations |
| T: +61 3 9639 6036 | T: +1 212 880 2060 |